Whistleblower Says Celgene Bribed Docs To Sell Cancer Meds
A former sales representative for Celgene Corp. is accusing the drugmaker of paying kickbacks to doctors for prescribing its cancer drugs Thalomid and Revlimid, and of marketing them for off-label uses...To view the full article, register now.
Already a subscriber? Click here to view full article